Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hirth

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1987
In vivo inorganic chemistry of technetium cationsE Deutsch, W Hirth
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Quantitative HPLC determination of [99mTc]-pertechnetate in radiopharmaceuticals and biological samples--I. Technique developmentT Z Zhou, W W Hirth, W R Heineman, et al.
Science (New York, N.Y.)|June 14, 1991
ROSAT Detection of an X-ray Shadow in the 1/4-keV Diffuse Background in the Draco NebulaS L Snowden, U Mebold, W Hirth, et al.
Nuclear Medicine and Biology|May 1, 1993
[99mTc] Teboroxime and [99mTc]Cl(DMG)3B2MP: binding characteristics andmetabolism of two [99mTc]BATOs in blood and tissuesK C Rosenspire, W L Rumsey, S Jurisson, et al.
Journal of Chromatography|February 7, 1992
Direct analysis of whole blood by internal surface reversed-phase chromatography: an examination of the binding and metabolism of technetium dioxime complexesK C Rosenspire, W Hirth, S Jurisson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humansE Deutsch, J L Vanderheyden, P Gerundini, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1998
Development of a sensitive and quantitative analytical method for 1H-4-substituted imidazole histamine H3-receptor antagonists utilizing high-performance liquid chromatography and dabsyl derivatizationM K Handley, W W Hirth, J G Phillips, et al.
Journal of Medicinal Chemistry|March 12, 1999
Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonistsS M Ali, C E Tedford, R Gregory, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Chloro----hydroxy substitution on technetium BATO [TcCl(dioxime)3 BR] complexesS S Jurisson, W Hirth, K E Linder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1986
Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agentsP Gerundini, A Savi, M C Gilardi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1987
In vivo inorganic chemistry of technetium cationsE Deutsch, W Hirth
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Quantitative HPLC determination of [99mTc]-pertechnetate in radiopharmaceuticals and biological samples--I. Technique developmentT Z Zhou, W W Hirth, W R Heineman, et al.
Science (New York, N.Y.)|June 14, 1991
ROSAT Detection of an X-ray Shadow in the 1/4-keV Diffuse Background in the Draco NebulaS L Snowden, U Mebold, W Hirth, et al.
Nuclear Medicine and Biology|May 1, 1993
[99mTc] Teboroxime and [99mTc]Cl(DMG)3B2MP: binding characteristics andmetabolism of two [99mTc]BATOs in blood and tissuesK C Rosenspire, W L Rumsey, S Jurisson, et al.
Journal of Chromatography|February 7, 1992
Direct analysis of whole blood by internal surface reversed-phase chromatography: an examination of the binding and metabolism of technetium dioxime complexesK C Rosenspire, W Hirth, S Jurisson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Development of nonreducible technetium-99m(III) cations as myocardial perfusion imaging agents: initial experience in humansE Deutsch, J L Vanderheyden, P Gerundini, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1998
Development of a sensitive and quantitative analytical method for 1H-4-substituted imidazole histamine H3-receptor antagonists utilizing high-performance liquid chromatography and dabsyl derivatizationM K Handley, W W Hirth, J G Phillips, et al.
Journal of Medicinal Chemistry|March 12, 1999
Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonistsS M Ali, C E Tedford, R Gregory, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Chloro----hydroxy substitution on technetium BATO [TcCl(dioxime)3 BR] complexesS S Jurisson, W Hirth, K E Linder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1986
Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agentsP Gerundini, A Savi, M C Gilardi, et al.
Pageof 1